Ventyx Biosciences Ownership 2024 | Who Owns Ventyx Biosciences Now?
Institutional Ownership
92.10%
Insider Ownership
3.31%
Retail Ownership
4.59%
Institutional Holders
117.00
Ventyx Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9.43% | 0.22% | 5,829,570 | 2,287,570 | 64.58% | 13,466,307 | Jun 30, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 8.49% | 0.00% | 5,247,646 | 2,893,497 | 122.91% | 12,122,062 | Jun 30, 2024 |
| BLACKROCK INC. | 7.72% | 0.00% | 4,771,657 | 1,024,564 | 27.34% | 11,022,528 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 5.13% | 0.03% | 3,170,000 | - | - | 7,322,700 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 5.01% | 0.73% | 3,100,000 | - | - | 7,161,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.84% | 0.00% | 2,994,242 | -711,230 | -19.19% | 6,916,699 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 3.87% | 0.87% | 2,391,114 | 890,000 | 59.29% | 5,523,473 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 3.50% | 0.30% | 2,164,126 | - | - | 4,999,131 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.36% | 0.00% | 1,459,131 | -224,957 | -13.36% | 3,370,592 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 2.13% | 0.23% | 1,315,000 | 1,315,000 | 100.00% | 3,037,650 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.13% | 0.00% | 1,314,352 | 207,542 | 18.75% | 3,036,516 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.92% | 0.63% | 1,190,000 | -95,000 | -7.39% | 2,748,900 | Jun 30, 2024 |
| STATE STREET CORP | 1.91% | 0.00% | 1,177,867 | 251,278 | 27.12% | 2,720,873,000 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 1.88% | 0.36% | 1,160,022 | -48,077 | -3.98% | 2,679,651 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 1.87% | 0.02% | 1,153,941 | -1,213,059 | -51.25% | 2,665,603 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.64% | 0.32% | 1,012,749 | 20,000 | 2.01% | 2,339,450 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.60% | 0.00% | 987,283 | 33,810 | 3.55% | 2,280,625 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 1.26% | 0.49% | 778,924 | 400,924 | 106.06% | 1,799,314 | Jun 30, 2024 |
| MORGAN STANLEY | 1.02% | 0.00% | 630,777 | -703,561 | -52.73% | 1,457,095 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.83% | 0.00% | 510,832 | 194,854 | 61.67% | 1,180,022 | Jun 30, 2024 |
Ventyx Biosciences's largest institutional shareholder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), holding 9.43% of the company's total share outstanding, currently valued at $13.47M. The top 10 institutional shareholders own together 52.47% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| QIMING U.S. VENTURES MANAGEMENT, LLC | 0.67% | 1.81% | 412,225 | - | - | 952,240 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 3.87% | 0.87% | 2,391,114 | 890,000 | 59.29% | 5,523,473 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 5.01% | 0.73% | 3,100,000 | - | - | 7,161,000 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.92% | 0.63% | 1,190,000 | -95,000 | -7.39% | 2,748,900 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 1.26% | 0.49% | 778,924 | 400,924 | 106.06% | 1,799,314 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 1.88% | 0.36% | 1,160,022 | -48,077 | -3.98% | 2,679,651 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.64% | 0.32% | 1,012,749 | 20,000 | 2.01% | 2,339,450 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 3.50% | 0.30% | 2,164,126 | - | - | 4,999,131 | Jun 30, 2024 |
| WEXFORD CAPITAL LP | 0.73% | 0.26% | 449,046 | 419,046 | 1396.82% | 1,037,296 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 2.13% | 0.23% | 1,315,000 | 1,315,000 | 100.00% | 3,037,650 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9.43% | 0.22% | 5,829,570 | 2,287,570 | 64.58% | 13,466,307 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.72% | 0.18% | 442,647 | -65,000 | -12.80% | 1,022,514 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 0.51% | 0.08% | 316,195 | -499,529 | -61.24% | 730,410 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.05% | 0.06% | 28,800 | - | - | 66,528 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 5.13% | 0.03% | 3,170,000 | - | - | 7,322,700 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.12% | 0.03% | 75,890 | 75,890 | 100.00% | 175,306 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 1.87% | 0.02% | 1,153,941 | -1,213,059 | -51.25% | 2,665,603 | Jun 30, 2024 |
| ALPHACENTRIC ADVISORS LLC | 0.02% | 0.02% | 10,000 | - | - | 23,100 | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | 0.06% | 0.02% | 38,126 | 38,126 | 100.00% | 88,071 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.04% | 0.01% | 25,303 | 25,303 | 100.00% | 58,450 | Jun 30, 2024 |
The largest Ventyx Biosciences shareholder by % of total assets is QIMING U.S. VENTURES MANAGEMENT, LLC. The company owns 412.23K shares of Ventyx Biosciences (VTYX), representing 1.81% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CAPITAL INTERNATIONAL INVESTORS | 8.49% | 0.00% | 5,247,646 | 2,893,497 | 122.91% | 12,122,062 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9.43% | 0.22% | 5,829,570 | 2,287,570 | 64.58% | 13,466,307 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 2.13% | 0.23% | 1,315,000 | 1,315,000 | 100.00% | 3,037,650 | Jun 30, 2024 |
| BLACKROCK INC. | 7.72% | 0.00% | 4,771,657 | 1,024,564 | 27.34% | 11,022,528 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 3.87% | 0.87% | 2,391,114 | 890,000 | 59.29% | 5,523,473 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.77% | 0.00% | 475,726 | 475,726 | 100.00% | 1,098,927 | Jun 30, 2024 |
| WEXFORD CAPITAL LP | 0.73% | 0.26% | 449,046 | 419,046 | 1396.82% | 1,037,296 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 1.26% | 0.49% | 778,924 | 400,924 | 106.06% | 1,799,314 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.61% | 0.01% | 379,175 | 379,175 | 100.00% | 875,894 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.43% | 0.00% | 263,565 | 263,565 | 100.00% | 608,000 | Jun 30, 2024 |
| STATE STREET CORP | 1.91% | 0.00% | 1,177,867 | 251,278 | 27.12% | 2,720,873,000 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.36% | 0.01% | 220,929 | 220,929 | 100.00% | 510,346 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.13% | 0.00% | 1,314,352 | 207,542 | 18.75% | 3,036,516 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.83% | 0.00% | 510,832 | 194,854 | 61.67% | 1,180,022 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.38% | 0.00% | 236,774 | 149,174 | 170.29% | 546,948 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.67% | 0.00% | 413,134 | 109,894 | 36.24% | 954,340 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.17% | 0.00% | 105,836 | 105,836 | 100.00% | 244,481 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.24% | 0.00% | 149,500 | 93,247 | 165.76% | 345,345 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.37% | 0.00% | 230,593 | 84,984 | 58.36% | 532,670 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.76% | 0.00% | 467,203 | 82,320 | 21.39% | 1,079,239 | Jun 30, 2024 |
As of Jun 30 2024, Ventyx Biosciences's largest institutional buyer is CAPITAL INTERNATIONAL INVESTORS. The company purchased 2.89M stocks of VTYX, valued at $12.12M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | - | - | - | -2,710,000 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -2,531,002 | -100.00% | - | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | - | - | - | -1,870,456 | -100.00% | - | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -1,265,050 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 1.87% | 0.02% | 1,153,941 | -1,213,059 | -51.25% | 2,665,603 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.84% | 0.00% | 2,994,242 | -711,230 | -19.19% | 6,916,699 | Jun 30, 2024 |
| MORGAN STANLEY | 1.02% | 0.00% | 630,777 | -703,561 | -52.73% | 1,457,095 | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | - | - | - | -624,842 | -100.00% | - | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 0.51% | 0.08% | 316,195 | -499,529 | -61.24% | 730,410 | Jun 30, 2024 |
| FMR LLC | 0.21% | - | 127,032 | -251,589 | -66.45% | 293,444 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.36% | 0.00% | 1,459,131 | -224,957 | -13.36% | 3,370,592 | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -169,498 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -163,922 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -134,000 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -120,700 | -100.00% | - | Jun 30, 2024 |
| PDT PARTNERS, LLC | - | - | - | -120,502 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.14% | 0.00% | 89,380 | -106,734 | -54.42% | 206,467 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.92% | 0.63% | 1,190,000 | -95,000 | -7.39% | 2,748,900 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.65% | 0.00% | 399,302 | -73,364 | -15.52% | 922,388 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.72% | 0.18% | 442,647 | -65,000 | -12.80% | 1,022,514 | Jun 30, 2024 |
As of Jun 30 2024, Ventyx Biosciences's biggest institutional seller is CORMORANT ASSET MANAGEMENT, LP. The company sold -2.71M shares of VTYX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VESTAL POINT CAPITAL, LP | 2.13% | 0.23% | 1,315,000 | 1,315,000 | 100.00% | 3,037,650 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.77% | 0.00% | 475,726 | 475,726 | 100.00% | 1,098,927 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.61% | 0.01% | 379,175 | 379,175 | 100.00% | 875,894 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.43% | 0.00% | 263,565 | 263,565 | 100.00% | 608,000 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.13% | 0.00% | 79,532 | 79,532 | 100.00% | 183,719 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.12% | 0.03% | 75,890 | 75,890 | 100.00% | 175,306 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.11% | 0.01% | 66,615 | 66,615 | 100.00% | 153,881 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.09% | 0.00% | 56,551 | 56,551 | 100.00% | 130,632 | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | 0.06% | 0.02% | 38,126 | 38,126 | 100.00% | 88,071 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 32,696 | 32,696 | 100.00% | 75,528 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.04% | 0.01% | 25,303 | 25,303 | 100.00% | 58,450 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 24,405 | 24,405 | 100.00% | 56,376 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.00% | - | 2,000 | 2,000 | 100.00% | 1,400 | Jun 30, 2024 |
| OPTIVER HOLDING B.V. | 0.00% | - | 498 | 498 | 100.00% | 1,150 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 25 | 25 | 100.00% | 58 | Jun 30, 2024 |
Ventyx Biosciences's largest new institutional shareholder by number of shares is VESTAL POINT CAPITAL, LP, purchased 1.31M shares, valued at $3.04M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | - | - | - | -2,710,000 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -2,531,002 | -100.00% | - | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | - | - | - | -1,870,456 | -100.00% | - | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -1,265,050 | -100.00% | - | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | - | - | - | -624,842 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -169,498 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -163,922 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -134,000 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -120,700 | -100.00% | - | Jun 30, 2024 |
| PDT PARTNERS, LLC | - | - | - | -120,502 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -62,262 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -60,850 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -44,911 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -37,547 | -100.00% | - | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | - | - | - | -33,490 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -23,064 | -100.00% | - | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -22,253 | -100.00% | - | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | - | - | - | -17,553 | -100.00% | - | Jun 30, 2024 |
| ZACKS INVESTMENT MANAGEMENT | - | - | - | -16,304 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -13,180 | -100.00% | - | Jun 30, 2024 |
| FNY INVESTMENT ADVISERS, LLC | - | - | - | -13,000 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -11,480 | -100.00% | - | Jun 30, 2024 |
| NORDEN GROUP LLC | - | - | - | -10,685 | -100.00% | - | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -5,177 | -100.00% | - | Jun 30, 2024 |
| BROWN BROTHERS HARRIMAN & CO | - | - | - | -2,845 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,579 | -100.00% | - | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -382 | -100.00% | - | Jun 30, 2024 |
| AVION WEALTH | - | - | - | -63 | -100.00% | - | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | - | - | - | -55 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -9 | -100.00% | - | Jun 30, 2024 |
Ventyx Biosciences's largest sold out institutional shareholder by shares sold is CORMORANT ASSET MANAGEMENT, LP, sold -2.71M shares, valued at -, as of undefined.
Ventyx Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Alger ETF Trust | 1.93% | 13,721 | - | - | Dec 31, 2023 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.61% | 562,853 | - | - | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.50% | 123,166 | - | - | Dec 31, 2023 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.37% | 430,000 | 430,000 | - | Mar 28, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.34% | 1,720,586 | - | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.24% | 784,454 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.20% | 1,689,919 | - | - | Jan 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.08% | 279,300 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.06% | 31,028 | - | - | Mar 31, 2024 |
| LORD ABBETT RESEARCH FUND INC | 0.06% | 54,446 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.05% | 121,000 | - | - | Mar 31, 2024 |
| ALGER FUNDS II | 0.04% | 8,808 | - | - | Jan 31, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.04% | 9,985 | - | - | Jan 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.03% | 274,800 | - | - | Mar 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.03% | 2,354,149 | - | - | Mar 31, 2024 |
| ALGER PORTFOLIOS | 0.03% | 11,126 | - | - | Dec 31, 2023 |
| FIDELITY CAPITAL TRUST | 0.03% | 296,460 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.03% | 24,827 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,574,852 | - | - | Feb 29, 2024 |
| VANGUARD HORIZON FUNDS | 0.02% | 550,898 | -59,242 | -9.71% | Mar 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.02% | 227,291 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.02% | 36,631 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.02% | 614,366 | - | - | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,951,441 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 65,093 | 49,484 | 317.02% | Feb 29, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.02% | 9,930 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.02% | 155,041 | - | - | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 83,204 | - | - | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.01% | 57,708 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 6,937 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.01% | 29,760 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.01% | 121,173 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.01% | 438,811 | -73,849 | -14.41% | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.01% | 103,893 | 39,348 | 60.96% | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.01% | 20,407 | 20,407 | - | Jan 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.01% | 25,337 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.01% | 55,309 | 4,066 | 7.93% | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,336 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 2,088,737 | -873,504 | -29.49% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 52,590 | 50,099 | 2011.20% | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 218,000 | - | - | Feb 29, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 20,300 | 17,311 | 579.16% | Mar 31, 2024 |
| FIDELITY CONTRAFUND | 0.00% | 244,070 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 106,210 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.00% | 8,000 | -702,800 | -98.87% | Mar 28, 2024 |
| ALPS ETF Trust | 0.00% | 41,595 | - | - | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 61,557 | 39,460 | 178.58% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 56,000 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 110,113 | -19,198 | -14.85% | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 23,075 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.00% | 2,825 | - | - | Jan 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 579,038 | - | - | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 4,650 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 333,806 | -111,364 | -25.02% | Feb 29, 2024 |
| Voya INVESTORS TRUST | 0.00% | 78,250 | 78,250 | - | Mar 31, 2024 |
| NUVEEN INVESTMENT FUNDS INC | 0.00% | 43,108 | - | - | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 2,770 | - | - | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 126,626 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 26,085 | 25,695 | 6588.46% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 21,396 | 396 | 1.89% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 28,521 | -2,143 | -6.99% | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 58,503 | - | - | Feb 29, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 12,500 | - | - | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 151,030 | 11,638 | 8.35% | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 3,995 | 3,995 | - | Aug 31, 2023 |
| Principal Exchange-Traded Funds | 0.00% | 6,888 | -214 | -3.01% | Mar 31, 2024 |
| OPTIMUM FUND TRUST | 0.00% | 22,520 | - | - | Mar 28, 2024 |
| LORD ABBETT SERIES FUND INC | 0.00% | 32,918 | - | - | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 76,885 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 15,219 | -3,733 | -19.70% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 1,960 | - | - | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 35,192 | 35,192 | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,038 | -401 | -16.44% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 219,866 | -17,302 | -7.30% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 732 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 16,700 | 1,900 | 12.84% | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 23,636 | - | - | Feb 29, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 7,946 | - | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 2,196 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS SECURITIES TRUST | 0.00% | 8,000 | - | - | Jan 31, 2024 |
| Victory Portfolios II | 0.00% | 11,694 | - | - | Mar 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 16,583 | - | - | Mar 31, 2024 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 1,199 | - | - | Feb 29, 2024 |
| LOOMIS SAYLES FUNDS II | 0.00% | 461,634 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 2,293 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 21,134 | 99 | 0.47% | Mar 28, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 44,175 | - | - | Jan 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 1,334 | 1,334 | - | Mar 28, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 25,400 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 1,983,770 | -90,904 | -4.38% | Mar 31, 2024 |
| LORD ABBETT INVESTMENT TRUST | 0.00% | 103,418 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 215,565 | 28,010 | 14.93% | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 109,256 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 124,058 | -5,956 | -4.58% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 427 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 17,960 | -73 | -0.40% | Feb 29, 2024 |
| BlackRock ETF Trust | 0.00% | 54 | - | - | Jan 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 27,064 | 1,157 | 4.47% | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 7,023 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 212 | - | - | Dec 31, 2023 |
Ventyx Biosciences's largest mutual fund holder by % of total assets is "Alger ETF Trust", owning 13.72K shares, compromising 1.93% of its total assets.
Ventyx Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 117 | -10.00% |
| 31 Mar, 24 | 130 | 4.00% |
| 31 Dec, 23 | 125 | -17.22% |
| 30 Sep, 23 | 151 | -5.63% |
| 30 Jun, 23 | 160 | 4.58% |
| 31 Mar, 23 | 153 | 17.69% |
| 31 Dec, 22 | 130 | 20.37% |
| 30 Sep, 22 | 108 | 80.00% |
| 30 Jun, 22 | 60 | 13.21% |
| 31 Mar, 22 | 53 | 15.22% |
| 31 Dec, 21 | 46 | - |
As of 30 Jun 24, 117 institutions are holding Ventyx Biosciences's shares, representing a decrease of -10.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 56,947,914 | -3.20% |
| 31 Mar, 24 | 58,833,410 | 36.04% |
| 31 Dec, 23 | 43,247,835 | -20.76% |
| 30 Sep, 23 | 54,581,513 | 3.40% |
| 30 Jun, 23 | 52,789,112 | 6.11% |
| 31 Mar, 23 | 49,749,769 | 16.58% |
| 31 Dec, 22 | 42,674,956 | 8.61% |
| 30 Sep, 22 | 39,290,275 | 13.45% |
| 30 Jun, 22 | 34,630,981 | 4.21% |
| 31 Mar, 22 | 33,233,202 | 5.15% |
| 31 Dec, 21 | 31,606,095 | - |
Ventyx Biosciences (VTYX) has 56.95M shares outstanding as of 30 Jun 24, down -3.20% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 92.10% | 0.93% |
| 31 Mar, 24 | 99.59% | 1.85% |
| 31 Dec, 23 | 73.45% | 0.85% |
| 30 Sep, 23 | 93.21% | 1.11% |
| 30 Jun, 23 | 91.59% | 1.23% |
| 31 Mar, 23 | 86.31% | 1.53% |
| 31 Dec, 22 | 75.23% | 1.30% |
| 30 Sep, 22 | 76.04% | 1.64% |
| 30 Jun, 22 | 68.11% | 1.58% |
| 31 Mar, 22 | 65.70% | 1.47% |
| 31 Dec, 21 | 66.86% | - |
As of 30 Jun 24, Ventyx Biosciences is held by 92.10% institutional shareholders, representing a 0.93% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 56 | -26.32% |
| 31 Mar, 24 | 76 | - |
| 31 Dec, 23 | 76 | 1.33% |
| 30 Sep, 23 | 75 | -25.74% |
| 30 Jun, 23 | 101 | 17.44% |
| 31 Mar, 23 | 86 | -7.53% |
| 31 Dec, 22 | 93 | 29.17% |
| 30 Sep, 22 | 72 | 94.59% |
| 30 Jun, 22 | 37 | 68.18% |
| 31 Mar, 22 | 22 | -52.17% |
| 31 Dec, 21 | 46 | - |
56 institutional shareholders have increased their position in VTYX stock as of 30 Jun 24 compared to 76 in the previous quarter (a -26.32% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 36 | -5.26% |
| 31 Mar, 24 | 38 | 15.15% |
| 31 Dec, 23 | 33 | -28.26% |
| 30 Sep, 23 | 46 | 43.75% |
| 30 Jun, 23 | 32 | -27.27% |
| 31 Mar, 23 | 44 | 100.00% |
| 31 Dec, 22 | 22 | 4.76% |
| 30 Sep, 22 | 21 | 61.54% |
| 30 Jun, 22 | 13 | -23.53% |
| 31 Mar, 22 | 17 | - |
| 31 Dec, 21 | - | - |
36 institutional shareholders have reduced their position in VTYX stock as of 30 Jun 24 compared to 38 in the previous quarter (a -5.26% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 117 | -10.00% | 56,947,914 | -3.20% | 92.10% | 0.93% | 56 | -26.32% | 36 | -5.26% |
| 31 Mar, 24 | 130 | 4.00% | 58,833,410 | 36.04% | 99.59% | 1.85% | 76 | - | 38 | 15.15% |
| 31 Dec, 23 | 125 | -17.22% | 43,247,835 | -20.76% | 73.45% | 0.85% | 76 | 1.33% | 33 | -28.26% |
| 30 Sep, 23 | 151 | -5.63% | 54,581,513 | 3.40% | 93.21% | 1.11% | 75 | -25.74% | 46 | 43.75% |
| 30 Jun, 23 | 160 | 4.58% | 52,789,112 | 6.11% | 91.59% | 1.23% | 101 | 17.44% | 32 | -27.27% |
| 31 Mar, 23 | 153 | 17.69% | 49,749,769 | 16.58% | 86.31% | 1.53% | 86 | -7.53% | 44 | 100.00% |
| 31 Dec, 22 | 130 | 20.37% | 42,674,956 | 8.61% | 75.23% | 1.30% | 93 | 29.17% | 22 | 4.76% |
| 30 Sep, 22 | 108 | 80.00% | 39,290,275 | 13.45% | 76.04% | 1.64% | 72 | 94.59% | 21 | 61.54% |
| 30 Jun, 22 | 60 | 13.21% | 34,630,981 | 4.21% | 68.11% | 1.58% | 37 | 68.18% | 13 | -23.53% |
| 31 Mar, 22 | 53 | 15.22% | 33,233,202 | 5.15% | 65.70% | 1.47% | 22 | -52.17% | 17 | - |
| 31 Dec, 21 | 46 | - | 31,606,095 | - | 66.86% | - | 46 | - | - | - |
Ventyx Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Ventyx Biosciences's stock was made by NSV Partners III LP on Jun 26 2024, selling 641,327 shares at - per share (valued at -).
Ventyx Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | - | - |
| Q2 2024 | 7 | 9 | 77.78% |
| Q1 2024 | 13 | 4 | 325.00% |
| Q4 2023 | 12 | 18 | 66.67% |
| Q3 2023 | 14 | 91 | 15.38% |
| Q2 2023 | 21 | 77 | 27.27% |
| Q1 2023 | 16 | 10 | 160.00% |
| Q4 2022 | 8 | 33 | 24.24% |
| Q3 2022 | - | 1 | - |
| Q2 2022 | 18 | 3 | 600.00% |
| Q1 2022 | 5 | - | - |
| Q4 2021 | 16 | 29 | 55.17% |
| Q1 2021 | - | 5 | - |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Ventyx Biosciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 4 | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | 10 | - |
| Q3 2023 | - | 73 | - |
| Q2 2023 | - | 57 | - |
| Q1 2023 | - | 4 | - |
| Q4 2022 | - | 24 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | 1 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 3 | - | - |
| Q1 2021 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Ventyx Biosciences's stocks.
Ventyx Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| DICE | DICE Therapeutics, Inc. |
| NUVL | Nuvalent, Inc. |
| IDYA | IDEAYA Biosciences, Inc. |
| IMCR | Immunocore Holdings plc |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| TVTX | Travere Therapeutics, Inc. |
| REPL | Replimune Group, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| ASND | Ascendis Pharma A/S |
| ACLX | Arcellx, Inc. |
| GPCR | Structure Therapeutics Inc. |
| PCVX | Vaxcyte, Inc. |
| UTHR | United Therapeutics Corporation |
| PTGX | Protagonist Therapeutics, Inc. |
| VRNA | Verona Pharma plc |
VTYX Ownership FAQ
Who Owns Ventyx Biosciences?
Ventyx Biosciences is owned by institutional shareholders (92.10%), insiders (3.31%), and public (4.59%). The largest institutional shareholder of Ventyx Biosciences is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (9.43% of total shares) and the top mutual fund owner is Alger ETF Trust (1.93% of total shares).
Who are the major institutional shareholders of Ventyx Biosciences?
Ventyx Biosciences's major institutional shareholders are DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), CAPITAL INTERNATIONAL INVESTORS, BLACKROCK INC., FARALLON CAPITAL MANAGEMENT LLC, and TANG CAPITAL MANAGEMENT LLC. The top five shareholders own together 35.77% of the company's share outstanding.
How many Ventyx Biosciences shareholders are there?
As of Jun 2024, there are 117 institutional shareholders of Ventyx Biosciences.
What percentage of Ventyx Biosciences is owned by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)?
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) owns 5.83M shares of Ventyx Biosciences, representing 9.43% of the company's total shares outstanding, valued at $13.47M (as of Jun 2024).
What percentage of Ventyx Biosciences is owned by CAPITAL INTERNATIONAL INVESTORS?
As of Jun 2024, CAPITAL INTERNATIONAL INVESTORS holds 5.25M shares of Ventyx Biosciences (VTYX), compromising 8.49% of the company, valued at $12.12M.
What percentage of Ventyx Biosciences is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Ventyx Biosciences. The company owns 4.77M of the company's shares outstanding (worth $11.02M).